These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9070576)

  • 21. Physiologic or pathologic hypertrophy: how can we know?
    Lai EJ; Rakowski H
    Expert Rev Cardiovasc Ther; 2014 Aug; 12(8):919-22. PubMed ID: 24972675
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma N-terminal pro-brain natriuretic peptide: a marker of left ventricular hypertrophy in hypertrophic cardiomyopathy.
    Brito D; Matias JS; Sargento L; Cabral MJ; Madeira HC
    Rev Port Cardiol; 2004 Dec; 23(12):1557-82. PubMed ID: 15732658
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Left ventricular hypertrophy diagnosed after a stroke: a case report.
    Umeojiako WI; Kanyal R
    J Med Case Rep; 2018 Mar; 12(1):76. PubMed ID: 29562910
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of coronary vasodilator reserve in elite rowing athletes versus hypertrophic cardiomyopathy.
    Radvan J; Choudhury L; Sheridan DJ; Camici PG
    Am J Cardiol; 1997 Dec; 80(12):1621-3. PubMed ID: 9416953
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relation of left ventricular chamber stiffness at rest to exercise capacity in hypertrophic cardiomyopathy.
    Dumont CA; Monserrat L; Peteiro J; Soler R; Rodriguez E; Bouzas A; Fernández X; Pérez R; Bouzas B; Castro-Beiras A
    Am J Cardiol; 2007 May; 99(10):1454-7. PubMed ID: 17493479
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical Course and Significance of Hypertrophic Cardiomyopathy Without Left Ventricular Hypertrophy.
    Maurizi N; Michels M; Rowin EJ; Semsarian C; Girolami F; Tomberli B; Cecchi F; Maron MS; Olivotto I; Maron BJ
    Circulation; 2019 Feb; 139(6):830-833. PubMed ID: 30715937
    [No Abstract]   [Full Text] [Related]  

  • 27. Specific heart muscle disease associated with glycogen storage disease type III: clinical similarity to the dilated phase of hypertrophic cardiomyopathy.
    Akazawa H; Kuroda T; Kim S; Mito H; Kojo T; Shimada K
    Eur Heart J; 1997 Mar; 18(3):532-3. PubMed ID: 9076400
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparison of left atrial size and function in hypertrophic cardiomyopathy and in Fabry disease with left ventricular hypertrophy.
    Saccheri MC; Cianciulli TF; Challapa Licidio W; Lax JA; Beck MA; Morita LA; Gagliardi JA;
    Echocardiography; 2018 May; 35(5):643-650. PubMed ID: 29457264
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypertrophic cardiomyopathy with progression from apical hypertrophy to asymmetrical septal hypertrophy: a case report.
    Kitaoka H; Kuwahara T; Nishida K; Morimoto K; Kubo T; Okawa M; Furuno T; Doi Y
    J Cardiol; 2005 Apr; 45(4):155-9. PubMed ID: 15875537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apical hypertrophic cardiomyopathy with giant negative T waves.
    Cassimatis DC; Atwood JE
    Mayo Clin Proc; 2005 Sep; 80(9):1245. PubMed ID: 16178511
    [No Abstract]   [Full Text] [Related]  

  • 31. Hypertrophic Cardiomyopathy, Athlete's Heart, or Both: A Case of Hypertrophic Cardiomyopathy Regression.
    Kebed KY; Bos JM; Anavekar NS; Mulvagh SL; Ackerman MJ; Ommen SR
    Circ Cardiovasc Imaging; 2015 Jul; 8(7):e003312. PubMed ID: 26162782
    [No Abstract]   [Full Text] [Related]  

  • 32. Prevalence of hypertrophic cardiomyopathy in highly trained athletes: relevance to pre-participation screening.
    Basavarajaiah S; Wilson M; Whyte G; Shah A; McKenna W; Sharma S
    J Am Coll Cardiol; 2008 Mar; 51(10):1033-9. PubMed ID: 18325444
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Left ventricular wall thickness in patients with hypertrophic cardiomyopathy: a comparison between cardiac magnetic resonance imaging and echocardiography.
    Corona-Villalobos CP; Sorensen LL; Pozios I; Chu L; Eng J; Abraham MR; Abraham TP; Kamel IR; Zimmerman SL
    Int J Cardiovasc Imaging; 2016 Jun; 32(6):945-54. PubMed ID: 26896038
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hypertrophic myocardiopathy (II). 24-hour electrocardiographic monitoring and its relation to the echocardiographic characteristics].
    de la Morena Valenzuela G; Ruipérez Abizanda JA; Picó Aracil F; Ruiz Ros JA; Campos Peris JV; Sánchez Muñoz JJ
    Rev Esp Cardiol; 1991 Mar; 44(3):168-73. PubMed ID: 2047547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The electrocardiogram as a diagnostic tool for hypertrophic cardiomyopathy: revisited.
    Maron BJ
    Ann Noninvasive Electrocardiol; 2001 Oct; 6(4):277-9. PubMed ID: 11686906
    [No Abstract]   [Full Text] [Related]  

  • 36. Significance and relation between magnitude of left ventricular hypertrophy and heart failure symptoms in hypertrophic cardiomyopathy.
    Maron MS; Zenovich AG; Casey SA; Link MS; Udelson JE; Aeppli DM; Maron BJ
    Am J Cardiol; 2005 Jun; 95(11):1329-33. PubMed ID: 15904638
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Physiological left ventricular hypertrophy or hypertrophic cardiomyopathy in an elite adolescent athlete: role of detraining in resolving the clinical dilemma.
    Basavarajaiah S; Wilson M; Junagde S; Jackson G; Whyte G; Sharma S; Roberts WO
    Br J Sports Med; 2006 Aug; 40(8):727-9; discussion 729. PubMed ID: 16864569
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of extent and distribution of left ventricular hypertrophy on clinical aspects and hemodynamics of patients with hypertrophic obstructive cardiomyopathy].
    Schwartzkopff B; Schwammenthal E; Lösse B; Steeg M; Strauer BE
    Z Kardiol; 1992 Jan; 81(1):15-24. PubMed ID: 1570724
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The role of magnetic resonance in studying hypertrophic cardiomyopathy: the echocardiographic correlations and clinical implications].
    Rapezzi C; Fattori R; Castriota F; Passarelli P; Magnani G; Galiè N; Ferlito M; Bertaccini P; Branzi A; Gavelli G
    Cardiologia; 1994 Jan; 39(1):7-15. PubMed ID: 8020058
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the electrocardiographic signs of left ventricular hypertrophy, using the echocardiography in patients with hypertensive cardiopathy.
    Guţiu I; Focşeneanu L; Rizescu R; Galeţescu E
    Rom J Intern Med; 1992; 30(3):187-92. PubMed ID: 1475596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.